ALPHA:ATHEXAlpha Bank S.A. Analysis
Data as of 2026-03-14 - not real-time
$301.46
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Alphabet’s stock is trading at $301.46, comfortably below its 20‑day ($306.20) and 50‑day ($319.21) moving averages, yet still above the 200‑day trend line, indicating a short‑term pull‑back within a longer‑term uptrend. The RSI of 40 signals mild oversold conditions, and the MACD histogram has turned positive, giving a bullish technical signal despite a neutral overall trend. Volume is decreasing, which tempers the upside, while the 30‑day volatility of 22.7% suggests the stock may experience sizable swings. Fundamentally, revenue is growing at 18% with a 59.7% gross margin and a 35.7% ROE, underscoring a high‑quality growth engine, but a trailing P/E of 27.86 versus an industry average of 17.77 points to an overvalued valuation; the DCF fair value of $94.90 is far below the market price. Analysts rate the stock a strong buy with a median target of $375, implying ~24% upside, and recent news highlights aggressive CapEx aimed at cementing an AI‑driven “agentic infrastructure” edge, reinforcing the growth narrative. The dividend yield is modest at 0.28% with a payout ratio under 8%, making the payout sustainable but not a primary driver. Overall, the blend of solid fundamentals, positive analyst sentiment, and strategic investments supports a bullish outlook, though short‑term price pressure near the $293.93 support level warrants caution.
Given the high valuation relative to peers, the stock’s upside is more dependent on continued growth acceleration and successful execution of its AI and cloud initiatives. Investors should weigh the overvaluation and elevated volatility against the strong earnings power and strategic positioning before deciding on entry timing.
Given the high valuation relative to peers, the stock’s upside is more dependent on continued growth acceleration and successful execution of its AI and cloud initiatives. Investors should weigh the overvaluation and elevated volatility against the strong earnings power and strategic positioning before deciding on entry timing.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price approaching $293.93 support level
- RSI near oversold territory
- Bullish MACD histogram despite decreasing volume
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Strong revenue growth and high margins
- Analyst consensus strong‑buy with median target $375
- Strategic CapEx driving AI/Cloud moat
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Sustained high ROE and cash flow generation
- Expanding AI infrastructure and cloud services
- Low dividend payout ratio supporting reinvestment
Key Metrics & Analysis
Financial Health
Revenue Growth18.00%
Profit Margin32.81%
P/E Ratio27.9
ROE35.71%
ROA15.43%
Debt/Equity16.13
P/B Ratio8.8
Op. Cash Flow$164.7B
Free Cash Flow$38.1B
Industry P/E17.8
Technical Analysis
TrendNeutral
RSI40.3
Support$293.93
Resistance$319.45
MA 20$306.20
MA 50$319.21
MA 200$257.13
MACDBullish
VolumeDecreasing
Fear & Greed Index72.88
Valuation
Fair Value$94.90
Target Price$359.53
Upside/Downside19.26%
GradeOvervalued
TypeGrowth
Dividend Yield0.28%
Risk Assessment
Beta0.98
Volatility22.67%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.